January 24, 2022
Daiichi Sankyo will wind up its marketing collaboration with Kitasato Pharmaceutical Industry for its mumps vaccine and measles-rubella vaccine at the end of March, the two companies said on January 21. Beginning on April 1, Daiichi Sankyo will independently conduct...read more